AVI BioPharma Inc. said Friday that its antisense drugs showed positive results against four lethal agents in preclinical studies conducted with Army researchers. Shares of AVI BioPharma Inc. rose 40 cents, or 14.8 percent, to $3.10 on the Nasdaq. Company shares have traded over the past 52 weeks in a range of $1.98 to $4.24.
